Patients undergoing elective coronary intervention (PCI) treatment.
Conditions
Interventions
Intervention 1: Control group: PCI with standard treatment (aspirin, statin, and beta-blocker). Intervention 2: Experimental group: PCI with standard treatment (aspirin, statin, and beta-blocker) with
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient undergoing elective PCI surgery over 40 years old. Consumption of 80 to 100 mg aspirin daily for at least 5 days before PCI Completion of informed consent No Consumption of other antioxidants including vitamins C and E, coenzyme Q10, selenium, anthocyanin supplements and lycopene supplements 1 week before study No use of fish oil and omega-3 by 1 week before study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of CK-MB, Troponin I and hs-CRP were measured in patients. Timepoint: Blood samples from both groups 12 hours before the intervention, 8 and 12 hours one and six months after the intervention. Method of measurement: 5 ml blood was taken from the patient to measure serum CK-MB, Troponin I and hs-CRP levels. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Rasoul Soltani
Esfahan University of Medical Sciences
Outcome results
None listed